Dissolution, Impurities & Pharmaceutical Method Development

Methods, applicability and limitations

High-level scope references only, not standards text or a claim about a current edition. Confirm product applicability, adopted edition, jurisdiction and provider authorization before ordering.

• USP <711> dissolution conditions and acceptance depend on the applicable monograph or approved procedure.
• ICH Q2 and Q14 address analytical validation/development; agreement is needed on procedure purpose, reportable range and suitability.
• Organic impurities, residual solvents and elemental impurities involve different guidance and exposure-based considerations; define the target class and justified limits.

Sample and project requirements

No universal sample quantity is promised. Ask the receiving provider to confirm containers, minimum amount, preparation, hazards, storage, transport and acceptance before collection or shipment.

• Dosage form, formulation, markets and applicable monograph/specification
• Batches, dissolution conditions, impurity targets and analytical standards
• Transfer/development scope, validation protocol and report responsibilities

Compare provider proposals

• Request the selected method, suitability work, controls, detection/reporting limits and stated exclusions.
• Confirm relevant experience, actual accredited or authorized scope where needed, subcontracting and quality responsibilities.
• Agree raw data, reviewed results, interpretation, confidentiality, price and a provider-confirmed schedule.
• Laboratory Vortex coordinates requests; independent providers perform the work. No capability, award, compliance or turnaround guarantee is implied.